Evidence map›Paper›PMID 41723156›Full record

ArticleNature communications2026

Engineering non-exponential proliferation in Escherichia coli using functionalized protein aggregates.

Ronald Van Eyken, Dries Oome, Kevin Broux, Sam Jordens, Abram Aertsen

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ronald Van EykenDepartment of Microbial and Molecular Systems, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0001-5579-0095
Dries OomeDepartment of Microbial and Molecular Systems, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0009-0007-5669-168X
Kevin BrouxDepartment of Microbial and Molecular Systems, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-4670-8544
Sam JordensDepartment of Microbial and Molecular Systems, KU Leuven, Leuven, Belgium.
Abram AertsenDepartment of Microbial and Molecular Systems, KU Leuven, Leuven, Belgium. abram.aertsen@kuleuven.be.ORCID http://orcid.org/0000-0002-1897-2305

Funding

Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 11J6222NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 11J6224NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 11Q4T24NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G0C5322NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G0D8220N
6 · The paper itself

Abstract

Microbes naturally grow exponentially, but this trait might not always be desirable for applications with genetically modified microorganisms. Especially in microorganisms engineered for therapeutic applications, uncurbed exponential proliferation might cause unpredictable liabilities in their behavior that in turn compromise their dosing and biocontainment. In an effort to fundamentally reprogram population growth dynamics, we constructed a bacterial chassis that adheres to linear proliferation for a finite number of generations. More specifically, growth of the chassis is directed by an intracellular protein aggregate that is engineered to reconstitute a split enzyme producing cAMP as a conditionally essential metabolite. Due to the asymmetric segregation and gradual disaggregation of this aggregate, it autonomously keeps growth restricted to the aggregate inheriting cell and to a limited number of divisions. By imposing such a transient and linear growth potential without the need for external intervention, this chassis offers a unique venue for the controlled application of engineered microorganisms.

Indexed as

Escherichia coliProtein AggregatesCyclic AMPEscherichia coli ProteinsCyclic AMPEscherichia coli ProteinsProtein Aggregates

Identifiers

PMID41723156
PMCPMC13035840

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.